DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Miyamoto S, Azuma K, Ishii H. et al
Low-dose erlotinib treatment in elderly or frail patients with EGFR mutation-positive non-small cell lung cancer: a multicenter phase 2 trial.
JAMA Oncol 2020;
6 (07) e201250
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.